| Literature DB >> 30356214 |
Haipeng Liu1,2, Haiping Zhang3, Xiangyang Wu1,2, Dapeng Ma2, Juehui Wu1,2, Lin Wang1,2, Yan Jiang2, Yiyan Fei4, Chenggang Zhu4, Rong Tan5, Peter Jungblut6, Gang Pei7, Anca Dorhoi7,8, Qiaoling Yan2, Fan Zhang9, Ruijuan Zheng1, Siyu Liu2, Haijiao Liang1,2, Zhonghua Liu1, Hua Yang1, Jianxia Chen1,2, Peng Wang2, Tianqi Tang2, Wenxia Peng2, Zhangsen Hu3, Zhu Xu3, Xiaochen Huang1, Jie Wang1, Haohao Li1, Yilong Zhou1,2, Feng Liu1, Dapeng Yan10, Stefan H E Kaufmann7, Chang Chen9, Zhiyong Mao11, Baoxue Ge12,13.
Abstract
Accurate repair of DNA double-stranded breaks by homologous recombination preserves genome integrity and inhibits tumorigenesis. Cyclic GMP-AMP synthase (cGAS) is a cytosolic DNA sensor that activates innate immunity by initiating the STING-IRF3-type I IFN signalling cascade1,2. Recognition of ruptured micronuclei by cGAS links genome instability to the innate immune response3,4, but the potential involvement of cGAS in DNA repair remains unknown. Here we demonstrate that cGAS inhibits homologous recombination in mouse and human models. DNA damage induces nuclear translocation of cGAS in a manner that is dependent on importin-α, and the phosphorylation of cGAS at tyrosine 215-mediated by B-lymphoid tyrosine kinase-facilitates the cytosolic retention of cGAS. In the nucleus, cGAS is recruited to double-stranded breaks and interacts with PARP1 via poly(ADP-ribose). The cGAS-PARP1 interaction impedes the formation of the PARP1-Timeless complex, and thereby suppresses homologous recombination. We show that knockdown of cGAS suppresses DNA damage and inhibits tumour growth both in vitro and in vivo. We conclude that nuclear cGAS suppresses homologous-recombination-mediated repair and promotes tumour growth, and that cGAS therefore represents a potential target for cancer prevention and therapy.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30356214 DOI: 10.1038/s41586-018-0629-6
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962